The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 524 KB) and Technical Notes (PDF, 762 KB) pages.



Download and Print: Download Printer-friendly PDF Download data


Table 22.22

Cancer of the Pancreas (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases, 2008-2012
Both Sexes by Race
Histologya All Races White Black Asian/
Pacific Islander
American Indian
/Alaska Nativeb
Hispanicc
Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent
Carcinoma 43,224 98.0% 34,469 98.0% 5,307 98.0% 3,085 98.1% 180 98.9% 4,332 97.7%
Epidermoid carcinomad (8051-8131) 107 0.2% 79 0.2% 16 0.3% - - - - - -
Adenocarcinomae 37,839 85.8% 30,239 86.0% 4,597 84.8% 2,691 85.6% 159 87.4% 3,773 85.1%
Adenocarcinoma, NOS (8140) 30,694 69.6% 24,489 69.6% 3,816 70.4% 2,128 67.7% 137 75.3% 3,069 69.2%
Papillary adenocarcinoma, NOS (8260) 43 0.1% 33 0.1% - - - - - - - -
Mucinous adenocarcinoma (8480,8482) 1,151 2.6% 920 2.6% 127 2.3% 89 2.8% - - 117 2.6%
Mucin-producing adenocarcinoma (8481) 400 0.9% 332 0.9% 44 0.8% 23 0.7% - - 37 0.8%
Infiltrating duct carcinoma (8500-8503,8507,8514) 4,392 10.0% 3,541 10.1% 460 8.5% 365 11.6% - - 399 9.0%
Other adenocarcinomaf 1,159 2.6% 924 2.6% 144 2.7% 82 2.6% - - 144 3.2%
Other specific carcinomasg 3,115 7.1% 2,488 7.1% 370 6.8% 230 7.3% - - 314 7.1%
Islet cell carcinoma (8150-8155) 344 0.8% 291 0.8% 34 0.6% - - - - 30 0.7%
Other carcinomash 2,771 6.3% 2,197 6.2% 336 6.2% 215 6.8% - - 284 6.4%
Unspecified, "Carcinoma, NOS" (8010,8020-8022) 2,164 4.9% 1,664 4.7% 324 6.0% 153 4.9% - - 240 5.4%
Sarcoma and other soft tissue tumorsi 33 0.1% 27 0.1% - - - - - - - -
Other specific typesj Unspecified (8000-8005) 40 0.1% 32 0.1% - - - - - - - -
799 1.8% 634 1.8% 101 1.9% 56 1.8% - - 91 2.1%
Total 44,098 100.0% 35,163 100.0% 5,418 100.0% 3,144 100.0% 182 100.0% 4,435 100.0%

Footnotes:

Source: SEER 18 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta, San Jose-Monterey, Los Angeles, Alaska Native Registry, Rural Georgia, California excluding SF/SJM/LA, Kentucky, Louisiana, New Jersey and Georgia excluding ATL/RG). Percents may not sum to 100 due to rounding.

a Excludes Kaposi Sarcoma, mesothelioma, lymphomas, leukemias, myelomas, lymphoreticular, and immunoproliferative diseases.

b Estimates for American Indian/Alaska Native are based on the CHSDA(Contract Health Service Delivery Area) counties.

c Hispanic is not mutually exclusive from whites, blacks, Asian/Pacific Islanders, and American Indians/Alaska Natives. Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry.

d Epidermoid carcinoma includes squamous, basal, and transitional cell carcinomas.

e Adenocarcinoma includes histologies 8050,8140-8147,8160-8162,8180-8221,8250-8507,8514,8520-8551,8560,8570-8574,8576,8940-8941.

f Other adenocarcinoma include histologies 8050,8141-8147,8160-8162,8180-8221,8250-8259,8261-8479,8483-8499,8504-8506,8520-8551, 8560,8570-8574,8576,8940-8941.

g Other specific carcinomas include histologies 8012-8015,8030-8046,8150-8155,8170-8180,8230-8249,8508,8510-8513,8561-8562,8575, 8580-8671.

h Other carcinomas include histologies 8012-8015,8030-8046,8170-8180,8230-8249,8508,8510-8513,8561-8562,8575,8580-8671.

i Sarcoma and other soft tissue tumors include histologies 8680-8713,8800-8921,8990-8991,9040-9044,9120-9136,9150-9252,9370-9373, 9540-9582.

j Other specific types include histologies 8720-8790,8930-8936,8950-9030,9060-9110,9260-9365,9380-9539.

- Statistic not shown due to fewer than 16 cases during the time period.

Page Navigation: << Previous Next >>


The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.